Tomoaki Ishigami
3PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 02, 2024
Analysis of clinical factors associated with Kampo formula-induced pseudoaldosteronism based on self-reported information from the Japanese Adverse Drug Event Report database.Kazushi Uneda, Yuki Kawai, Akira Kaneko
|Aug 02, 2020
Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis.Lin Chen, Tomoaki Ishigami, Hiroshi Doi
|Jun 18, 2019
Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.Kentaro Arakawa, Tomoaki Ishigami, Michiko Nakai-Sugiyama
Pageof 1
